Summary
Apolipoproteins AIV, B, E, and the Lp(a) glycoprotein are genetically polymorphic in humans. Three common alleles ε2, ε3 and ε4 control the polymorphism of apolipoprotein E. These code for proteins which differ in functional properties, e.g. receptor binding activity and in vivo catabolism. This explains the significant effect of the apoE gene locus on the variability of plasma lipoprotein concentrations and moreover the implication of apoE alleles in the aetiology of multifactorial forms of hyperlipidaemia e.g. familial type III hyperlipidaemia (apoE2; arg158→cys) and polygenic hypercholesterolemia (apoE4; cysll2→arg). A further gene locus controls the concentrations in plasma of the Lp(a) lipoprotein that is composed of an LDL-like particle containing apoB-100 and the disulphide-bonded Lp(a) glycoprotein. The latter exhibits a genetic size polymorphism (MW∼400kD–700kD) that is controlled by at least seven autosomal alleles. These alleles at the same time are involved in determining the plasma concentrations of the lipoprotein that range from <1mg/dl to >200mg/dl. Thus there is evidence that genetic variability in apolipoproteins relates to the variability of lipoprotein concentrations in the population and is implicated in the aetiology of multifactorial hyperlipidaemias.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albers, J. J. and Hazzard, W. R. Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids 9 (1974) 15–26
Berg, K. A new serum type system in man: the Lp-system. Acta Pathol. Microbiol. Scand. 59 (1963) 369–382
Berg, K, Dahlen, G. and Frick, M. H. Lp(a) lipoprotein and pre-β-lipoprotein in patients with coronary heart disease. Clin. Genet. 6 (1974) 230–235.
Boerwinkle, E. and Utermann, G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B and cholesterol metabolism. Am. J. Hum. Genet. 78 (1988) 41–46
Breslow, J. L. Human apolipoprotein molecular biology and genetic variation. Annu. Rev. Biochem. 54 (1985) 699–727
Brown, M. S. and Goldstein, J. L. A receptor mediated pathway for cholesterol homeostasis. Science 232 (1986) 34–47
Dolphin, P.J. Lipoprotein metabolism and the role of apolipoproteins as metabolic programmers. Can. J. Biochem. Cell. Biol. 63 (1985) 850–869
Eaton, D. L., Fless, G. M., Kohr, W. J., McLean, J. W., Xu, Q.-T., Miller, C. G., Lawn, R. W. and Scanu, A. M. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc. Natl. Acad. Sci. USA 84 (1987) 3224–3228
Ehnholm, C., Garoff, H., Renkonen, O. and Simons, K. Protein and carbohydrate composition of Lp(a) lipoprotein from human plasma. Biochemistry 11 (1972) 3229–3232
Fless, G. M., Rolik, C. A. and Scanu, A. M. Heterogeneity of human plasma lipoprotein(a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J. Biol. Chem. 259 (1984) 11470–11478
Gaubatz, J. W., Heideman, C., Gotto, Jr. A. M., Morrisett, J. D. and Dahlen, G. H. Human plasma lipoprotein(a): structural properties. J. Biol. Chem. 258 (1983) 4582–4589
Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D. and Brewer, Jr. H. B. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J. Clin. Invest. 78 (1986) 815–821
Hasstedt, S. J. and Williams, R. R. Three alleles for quantitative Lp(a). Genet. Epidemiol. 3 (1986) 53–55
Havekes, L., De Wit, E., Gevers-Leuven, J., Klasen, E., Utermann, G., Weber, W. and Beisiegel, U. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum. Genet. 73 (1986) 157–163
Hazzard, W. R., Warnick, G. R., Utermann, G. and Albers, J. J. Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinaemia and hyperlipidaemia. Metabolism 30 (1981) 79–88
Klasen, E. C., Talmud, P. J., Havekes, L., De Wit, E., Van der Kooij-Meijs, E., Smit, M., Hansson, G. and Humphries, S. E. A common restriction fragment length polymorphism of the human apo E gene and its relationship to type III hyperlipidaemia. Hum. Genet. 75 (1987) 244–247
Kostner, G. M., Avorgaro, P., Cazzoloto, G., Marth, E., Bittolo-Bon, G. and Quini, G. B. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38 (1981) 51–61
Mahley, R. W., Innerarity, T. L., Rail, S. C. and Weisgraber, K. H. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25 (1984) 1277–1294
Menzel, H. J., Kövary, P. M. and Assmann, G. Apolipoprotein A-IV polymorphism in man. Hum. Genet. 62 (1982) 349–352
Menzel, H. J. and Utermann, G. Apolipoprotein phenotyping from serum by western blotting. Electrophoresis 1 (1986) 492–495
Rall, S. C., Weisgraber, K. H., Innerarity, T. L. and Mahley, R. W. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoprotein subjects. Proc. Natl. Acad. Sci. USA 19 (1982) 4696–4700
Rall, S. C., Weisgraber, K. H., Innerarity, T. L., Mahley, R. W. and Assman, G. Identical structural and receptor binding defects in apolipoprotein E2 in hypo- normo- and hypercholesterolemic dysbetalipoproteinia. J. Clin. Invest. 71 (1983) 1023–1031
Renninger W., Wendt, G. G., Nawrocki, P. and Weigand, H. Beitrag zur Problematik des Lp-Systems. Humangenetik 1 (1965) 658–667
Rhoads, G. G., Dahlen, G., Berg, K, Morton, N. E. and Dannenberg, A. L. Lp(a) lipoprotein as a risk factor for myocardial infarction. J. Am. Med. Assoc. 256 (1986) 2540–2544
Robertson, F. W. and Cumming, A. M. Effects of apoprotein E polymorphism of serum lipoprotein concentration. Arteriosclerosis 5 (1985) 283–292
Schneider, W. J., Kovanen, P. T., Brown, M. S., Goldstein, J. L., Utermann, G., Weber, W., Havel, R. J., Kotite, L., Kane, J. P., Innerarity, T. L. and Mahley, R. W. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenals of rats, rabbits and cows. J. Clin. Invest. 68 (1981) 1075–1085
Sing, C. F., Schultz, J. S. and Shreffler, D. C. The genetics of the Lp-antigen II. Ann. Hum. Genet. 38 (1974) 47–56
Sing, C. F. and Davignon, J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Ann. Hum. Genet. 37 (1985) 268–284
Utermann, G. Genetic polymorphism of apolipoprotein E — impact on plasma lipoprotein metabolism. In Crepaldi, G. (ed.) Diabetes, Obesity and Hyperlipidemias — III. Elsevier Science Publishers, New York, 1985, pp. 1–28
Utermann, G. Apolipoprotein E polymorphism in health and disease. Am. Heart J. 113 (1987) 433–440
Utermann, G., Jaeschke, M. and Menzel, H. J. Familial hyperlipoproteinaemia type III: deficiency of a specific apolipoprotein (apoE III) in the very-low-density lipoproteins. FEBS Lett. 56 (1975) 352–355
Utermann, G., Hees, M. and Steinmetz, A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature (1977a) 604–607
Utermann, G., Canzler, H., Hees, M., Jaeschke, M., Mühlfellner, G., Schoenborn, W. and Vogelberg, K. H. Studies on the metabolic defect in Broad-β-disease (hyperlipoproteinaemia type III). Clin. Genet. 12 (1977b) 139–154
Utermann, G., Pruin, N. and Steinmetz, A. Polymorphism of apolipoprotein E. Ill: Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin. Genet. 15 (1979a) 63–72
Utermann, G., Vogelberg, K. H. and Steinmetz, A. et al. Polymorphism of apolipoprotein E: II: Genetics of hyperlipoproteinaemia type III. Clin. Genet. 15 (1979b) 37–62
Utermann, G., Feussner, G., Franceschini, G. and Steinmetz, A. Genetic variants of group A apolipoproteins. J. Biol. Chem. 257 (1982) 501–507
Utermann, G., Kindermann, I., Kaffarnik, H. and Steinmetz, A. Apolipoprotein E pheno-types and hyperlipidaemia. Hum. Genet. 65 (1984) 232–236
Utermann, G., Menzel, H. J., Kraft, H. G., Duba, H. C., Kemmler, H. G. and Seiss, C. Lp(a) glycoprotein in phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentration in plasma. J. Clin. Invest. 80 (1987) 458–465
Utermann, G., Kraft, H G., Menzel, H. J., Hopferwieser, T. and Seiss, C. Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum. Genet. 78 (1988a) 41–46
Utermann, G., Duba, C. and Menzel, H. J. Genetics of the quantitative Lp(a) lipoprotein trait. II. Inheritance of Lp(a) glycoprotein phenotypes. Hum. Genet. 78 (1988b) 47–50
Weisgraber, K. H., Innerarity, T. L. and Mahley, R. W. Abnormal lipoprotein receptor- binding activity of human E apoprotein due to cysteine arginine interchange at a single site. J. Biol. Chem. 257 (1982) 2518–2521
Wiegandt, H., Lipp, K. and Wendt, G. Identifizierung eines Lipoproteins mit Antigen Wirksamkeit im Lp-System. Hoppe-Seyler’s Z. Physiol. Chem. 349 (1968) 489 - 494
Zannis, V. I. and Breslow, J. L. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry 20 (1981) 1033–1041
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Utermann, G. (1988). Apolipoprotein Polymorphism and Multifactorial Hyperlipidaemia. In: Pollitt, R.J., Harkness, R.A., Addison, G.M. (eds) Studies in Inherited Metabolic Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1259-5_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-1259-5_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7059-1
Online ISBN: 978-94-009-1259-5
eBook Packages: Springer Book Archive